Bibliome.ai browser hg19
Search
About
Stats
FAQ
ERBB2 c.1487C>T ;(p.T496I)
Variant ID: 17-37872166-C-T
NM_004448.2(
ERBB2
):c.1487C>T;(p.T496I)
This variant was identified in 5 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer.
Peerj
Zhu, Wei W; Huang, Meiyuan M; Thakur, Abhimanyu A; Yan, Yuanliang Y; Wu, Xiaoying X
Publication Date: 2023
Variant appearance in text: ERBB2: 1487C>T
PubMed Link:
36751636
Variant Present in the following documents:
peerj-11-14827-s010.xlsx, sheet 1
View BVdb publication page
Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.
Cancer Medicine
Liu, Binliang B; Yi, Zongbi Z; Guan, Yanfang Y; Ouyang, Quchang Q; Li, Chunxiao C; Guan, Xiuwen X; Lv, Dan D; Li, Lixi L; Zhai, Jingtong J; Qian, Haili H; Xu, Binghe B; Ma, Fei F; Zeng, Yixin Y
Publication Date: 2022-07
Variant appearance in text: ERBB2: 1487C>T; T496I
PubMed Link:
35393784
Variant Present in the following documents:
CAM4-11-2767-s001.xlsx, sheet 1
View BVdb publication page
Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast.
Communications Biology
Nagasawa, Satoi S; Kuze, Yuta Y; Maeda, Ichiro I; Kojima, Yasuyuki Y; Motoyoshi, Ai A; Onishi, Tatsuya T; Iwatani, Tsuguo T; Yokoe, Takamichi T; Koike, Junki J; Chosokabe, Motohiro M; Kubota, Manabu M; Seino, Hibiki H; Suzuki, Ayako A; Seki, Masahide M; Tsuchihara, Katsuya K; Inoue, Eisuke E; Tsugawa, Koichiro K; Ohta, Tomohiko T; Suzuki, Yutaka Y
Publication Date: 2021-04-01
Variant appearance in text: ERBB2: T496I
PubMed Link:
33795819
Variant Present in the following documents:
42003_2021_1959_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page
Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer.
Npj Breast Cancer
Yi, Zongbi Z; Rong, Guohua G; Guan, Yanfang Y; Li, Jin J; Chang, Lianpeng L; Li, Hui H; Liu, Binliang B; Wang, Wenna W; Guan, Xiuwen X; Ouyang, Quchang Q; Li, Lixi L; Zhai, Jingtong J; Li, Chunxiao C; Li, Lifeng L; Xia, Xuefeng X; Yang, Ling L; Qian, Haili H; Yi, Xin X; Xu, Binghe B; Ma, Fei F
Publication Date: 2020
Variant appearance in text: ERBB2: 1487C>T; T496I
PubMed Link:
33145402
Variant Present in the following documents:
41523_2020_201_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page
Novel insights into breast cancer genetic variance through RNA sequencing.
Scientific Reports
Horvath, Anelia A; Pakala, Suresh Babu SB; Mudvari, Prakriti P; Reddy, Sirigiri Divijendra Natha SD; Ohshiro, Kazufumi K; Casimiro, Sandra S; Pires, Ricardo R; Fuqua, Suzanne A W SA; Toi, Masakazu M; Costa, Luis L; Nair, Sujit S SS; Sukumar, Saraswati S; Kumar, Rakesh R
Publication Date: 2013
Variant appearance in text: HER2: 1487C>T
PubMed Link:
23884293
Variant Present in the following documents:
Main text
View BVdb publication page